Esophageal metastasis of breast carcinoma

Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast cancer (Tokyo, Japan) Japan), 2009-04, Vol.16 (2), p.151-156
Hauptverfasser: Wada, Yasuo, Harada, Nobuko, Ohara, Kazuhiro, Kawata, Hironori, Iwasaki, Hironori, Kawamura, Yuuichiro, Gomi, Takashi, Ohtoshi, Masahiro, Nakashima, Yasuaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 156
container_issue 2
container_start_page 151
container_title Breast cancer (Tokyo, Japan)
container_volume 16
creator Wada, Yasuo
Harada, Nobuko
Ohara, Kazuhiro
Kawata, Hironori
Iwasaki, Hironori
Kawamura, Yuuichiro
Gomi, Takashi
Ohtoshi, Masahiro
Nakashima, Yasuaki
description Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer treatment, with no apparent tumor recurrence. After 2 years absence, she consulted our clinic with progressive dysphagia. Contrast esophagography and endoscopic examination with ultrasonography revealed a protruding submucosal tumor that was histopathologically diagnosed as esophageal metastasis of breast cancer. Radiation therapy involving a total of 60 Gy in combination with aromatase inhibitor was given. The patient’s dysphagia was greatly relieved, concomitant with marked improvement of the stenotic lesion on imaging. Since treatment for recurrent breast cancer is generally palliative, systemic (chemo- and/or endocrine-) therapy in combination with radiotherapy is the first-line option for esophageal metastasis of breast cancer.
doi_str_mv 10.1007/s12282-008-0068-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67101535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67101535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-752d4500f3968668047a2d770fcd6f00e92dd3997a82ca69ebc20b22c7084ffd3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZ_gBfZk-AhOkl2k-xRSqtCwYueQzYfdcvupibdg__elC14EzJkhnnnHeZB6JbAIwEQT4lQKikGkDm4xPwMzYmUgEvK2HnOWQmYSy5n6CqlHUDJBPBLNCNScCo5m6OHVQr7L711uit6d9ApvzYVwRdNdLkqjI6mHUKvr9GF111yN6d_gT7Xq4_lK968v7wtnzfYsLo6YFFRW1YAntV5M5dQCk2tEOCN5R7A1dRaVtdCS2o0r11jKDSUGgGy9N6yBbqffPcxfI8uHVTfJuO6Tg8ujElxQYBUrMpCMglNDClF59U-tr2OP4qAOvJREx-V-agjH8XzzN3JfGx6Z_8mTkCygE6ClFvD1kW1C2Mc8sH_uP4CDiZuyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67101535</pqid></control><display><type>article</type><title>Esophageal metastasis of breast carcinoma</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Wada, Yasuo ; Harada, Nobuko ; Ohara, Kazuhiro ; Kawata, Hironori ; Iwasaki, Hironori ; Kawamura, Yuuichiro ; Gomi, Takashi ; Ohtoshi, Masahiro ; Nakashima, Yasuaki</creator><creatorcontrib>Wada, Yasuo ; Harada, Nobuko ; Ohara, Kazuhiro ; Kawata, Hironori ; Iwasaki, Hironori ; Kawamura, Yuuichiro ; Gomi, Takashi ; Ohtoshi, Masahiro ; Nakashima, Yasuaki</creatorcontrib><description>Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer treatment, with no apparent tumor recurrence. After 2 years absence, she consulted our clinic with progressive dysphagia. Contrast esophagography and endoscopic examination with ultrasonography revealed a protruding submucosal tumor that was histopathologically diagnosed as esophageal metastasis of breast cancer. Radiation therapy involving a total of 60 Gy in combination with aromatase inhibitor was given. The patient’s dysphagia was greatly relieved, concomitant with marked improvement of the stenotic lesion on imaging. Since treatment for recurrent breast cancer is generally palliative, systemic (chemo- and/or endocrine-) therapy in combination with radiotherapy is the first-line option for esophageal metastasis of breast cancer.</description><identifier>ISSN: 1340-6868</identifier><identifier>EISSN: 1880-4233</identifier><identifier>DOI: 10.1007/s12282-008-0068-6</identifier><identifier>PMID: 18762863</identifier><language>eng</language><publisher>Japan: Springer Japan</publisher><subject>Aged ; Antineoplastic Agents, Hormonal - therapeutic use ; Breast Neoplasms - drug therapy ; Breast Neoplasms - pathology ; Breast Neoplasms - radiotherapy ; Cancer Research ; Carcinoma, Ductal, Breast - drug therapy ; Carcinoma, Ductal, Breast - radiotherapy ; Carcinoma, Ductal, Breast - secondary ; Case Report ; Combined Modality Therapy ; Esophageal Neoplasms - drug therapy ; Esophageal Neoplasms - radiotherapy ; Esophageal Neoplasms - secondary ; Female ; Humans ; Medicine ; Medicine &amp; Public Health ; Oncology ; Radiotherapy Dosage ; Surgery ; Surgical Oncology ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>Breast cancer (Tokyo, Japan), 2009-04, Vol.16 (2), p.151-156</ispartof><rights>The Japanese Breast Cancer Society 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-752d4500f3968668047a2d770fcd6f00e92dd3997a82ca69ebc20b22c7084ffd3</citedby><cites>FETCH-LOGICAL-c395t-752d4500f3968668047a2d770fcd6f00e92dd3997a82ca69ebc20b22c7084ffd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12282-008-0068-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12282-008-0068-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18762863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wada, Yasuo</creatorcontrib><creatorcontrib>Harada, Nobuko</creatorcontrib><creatorcontrib>Ohara, Kazuhiro</creatorcontrib><creatorcontrib>Kawata, Hironori</creatorcontrib><creatorcontrib>Iwasaki, Hironori</creatorcontrib><creatorcontrib>Kawamura, Yuuichiro</creatorcontrib><creatorcontrib>Gomi, Takashi</creatorcontrib><creatorcontrib>Ohtoshi, Masahiro</creatorcontrib><creatorcontrib>Nakashima, Yasuaki</creatorcontrib><title>Esophageal metastasis of breast carcinoma</title><title>Breast cancer (Tokyo, Japan)</title><addtitle>Breast Cancer</addtitle><addtitle>Breast Cancer</addtitle><description>Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer treatment, with no apparent tumor recurrence. After 2 years absence, she consulted our clinic with progressive dysphagia. Contrast esophagography and endoscopic examination with ultrasonography revealed a protruding submucosal tumor that was histopathologically diagnosed as esophageal metastasis of breast cancer. Radiation therapy involving a total of 60 Gy in combination with aromatase inhibitor was given. The patient’s dysphagia was greatly relieved, concomitant with marked improvement of the stenotic lesion on imaging. Since treatment for recurrent breast cancer is generally palliative, systemic (chemo- and/or endocrine-) therapy in combination with radiotherapy is the first-line option for esophageal metastasis of breast cancer.</description><subject>Aged</subject><subject>Antineoplastic Agents, Hormonal - therapeutic use</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - radiotherapy</subject><subject>Cancer Research</subject><subject>Carcinoma, Ductal, Breast - drug therapy</subject><subject>Carcinoma, Ductal, Breast - radiotherapy</subject><subject>Carcinoma, Ductal, Breast - secondary</subject><subject>Case Report</subject><subject>Combined Modality Therapy</subject><subject>Esophageal Neoplasms - drug therapy</subject><subject>Esophageal Neoplasms - radiotherapy</subject><subject>Esophageal Neoplasms - secondary</subject><subject>Female</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Radiotherapy Dosage</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>1340-6868</issn><issn>1880-4233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlZ_gBfZk-AhOkl2k-xRSqtCwYueQzYfdcvupibdg__elC14EzJkhnnnHeZB6JbAIwEQT4lQKikGkDm4xPwMzYmUgEvK2HnOWQmYSy5n6CqlHUDJBPBLNCNScCo5m6OHVQr7L711uit6d9ApvzYVwRdNdLkqjI6mHUKvr9GF111yN6d_gT7Xq4_lK968v7wtnzfYsLo6YFFRW1YAntV5M5dQCk2tEOCN5R7A1dRaVtdCS2o0r11jKDSUGgGy9N6yBbqffPcxfI8uHVTfJuO6Tg8ujElxQYBUrMpCMglNDClF59U-tr2OP4qAOvJREx-V-agjH8XzzN3JfGx6Z_8mTkCygE6ClFvD1kW1C2Mc8sH_uP4CDiZuyw</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Wada, Yasuo</creator><creator>Harada, Nobuko</creator><creator>Ohara, Kazuhiro</creator><creator>Kawata, Hironori</creator><creator>Iwasaki, Hironori</creator><creator>Kawamura, Yuuichiro</creator><creator>Gomi, Takashi</creator><creator>Ohtoshi, Masahiro</creator><creator>Nakashima, Yasuaki</creator><general>Springer Japan</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090401</creationdate><title>Esophageal metastasis of breast carcinoma</title><author>Wada, Yasuo ; Harada, Nobuko ; Ohara, Kazuhiro ; Kawata, Hironori ; Iwasaki, Hironori ; Kawamura, Yuuichiro ; Gomi, Takashi ; Ohtoshi, Masahiro ; Nakashima, Yasuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-752d4500f3968668047a2d770fcd6f00e92dd3997a82ca69ebc20b22c7084ffd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Aged</topic><topic>Antineoplastic Agents, Hormonal - therapeutic use</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - radiotherapy</topic><topic>Cancer Research</topic><topic>Carcinoma, Ductal, Breast - drug therapy</topic><topic>Carcinoma, Ductal, Breast - radiotherapy</topic><topic>Carcinoma, Ductal, Breast - secondary</topic><topic>Case Report</topic><topic>Combined Modality Therapy</topic><topic>Esophageal Neoplasms - drug therapy</topic><topic>Esophageal Neoplasms - radiotherapy</topic><topic>Esophageal Neoplasms - secondary</topic><topic>Female</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Radiotherapy Dosage</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wada, Yasuo</creatorcontrib><creatorcontrib>Harada, Nobuko</creatorcontrib><creatorcontrib>Ohara, Kazuhiro</creatorcontrib><creatorcontrib>Kawata, Hironori</creatorcontrib><creatorcontrib>Iwasaki, Hironori</creatorcontrib><creatorcontrib>Kawamura, Yuuichiro</creatorcontrib><creatorcontrib>Gomi, Takashi</creatorcontrib><creatorcontrib>Ohtoshi, Masahiro</creatorcontrib><creatorcontrib>Nakashima, Yasuaki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wada, Yasuo</au><au>Harada, Nobuko</au><au>Ohara, Kazuhiro</au><au>Kawata, Hironori</au><au>Iwasaki, Hironori</au><au>Kawamura, Yuuichiro</au><au>Gomi, Takashi</au><au>Ohtoshi, Masahiro</au><au>Nakashima, Yasuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Esophageal metastasis of breast carcinoma</atitle><jtitle>Breast cancer (Tokyo, Japan)</jtitle><stitle>Breast Cancer</stitle><addtitle>Breast Cancer</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>16</volume><issue>2</issue><spage>151</spage><epage>156</epage><pages>151-156</pages><issn>1340-6868</issn><eissn>1880-4233</eissn><abstract>Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer treatment, with no apparent tumor recurrence. After 2 years absence, she consulted our clinic with progressive dysphagia. Contrast esophagography and endoscopic examination with ultrasonography revealed a protruding submucosal tumor that was histopathologically diagnosed as esophageal metastasis of breast cancer. Radiation therapy involving a total of 60 Gy in combination with aromatase inhibitor was given. The patient’s dysphagia was greatly relieved, concomitant with marked improvement of the stenotic lesion on imaging. Since treatment for recurrent breast cancer is generally palliative, systemic (chemo- and/or endocrine-) therapy in combination with radiotherapy is the first-line option for esophageal metastasis of breast cancer.</abstract><cop>Japan</cop><pub>Springer Japan</pub><pmid>18762863</pmid><doi>10.1007/s12282-008-0068-6</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1340-6868
ispartof Breast cancer (Tokyo, Japan), 2009-04, Vol.16 (2), p.151-156
issn 1340-6868
1880-4233
language eng
recordid cdi_proquest_miscellaneous_67101535
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Aged
Antineoplastic Agents, Hormonal - therapeutic use
Breast Neoplasms - drug therapy
Breast Neoplasms - pathology
Breast Neoplasms - radiotherapy
Cancer Research
Carcinoma, Ductal, Breast - drug therapy
Carcinoma, Ductal, Breast - radiotherapy
Carcinoma, Ductal, Breast - secondary
Case Report
Combined Modality Therapy
Esophageal Neoplasms - drug therapy
Esophageal Neoplasms - radiotherapy
Esophageal Neoplasms - secondary
Female
Humans
Medicine
Medicine & Public Health
Oncology
Radiotherapy Dosage
Surgery
Surgical Oncology
Tomography, X-Ray Computed
Treatment Outcome
title Esophageal metastasis of breast carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T15%3A10%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Esophageal%20metastasis%20of%20breast%20carcinoma&rft.jtitle=Breast%20cancer%20(Tokyo,%20Japan)&rft.au=Wada,%20Yasuo&rft.date=2009-04-01&rft.volume=16&rft.issue=2&rft.spage=151&rft.epage=156&rft.pages=151-156&rft.issn=1340-6868&rft.eissn=1880-4233&rft_id=info:doi/10.1007/s12282-008-0068-6&rft_dat=%3Cproquest_cross%3E67101535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67101535&rft_id=info:pmid/18762863&rfr_iscdi=true